Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches

Continuous development of personalized treatments is undoubtedly beneficial for oncogenic patients’ comfort and survival rate. Mutant TP53 is associated with a worse prognosis due to the occurrence of metastases, increased chemoresistance, and tumor growth. Currently, numerous compounds capable of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Roszkowska, Katarzyna A., Piecuch, Aleksandra, Sady, Maria, Gajewski, Zdzisław, Flis, Sylwia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654280/
https://www.ncbi.nlm.nih.gov/pubmed/36362074
http://dx.doi.org/10.3390/ijms232113287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654280/
https://www.ncbi.nlm.nih.gov/pubmed/36362074
http://dx.doi.org/10.3390/ijms232113287

Ejemplares similares